• TargetScan Touch
  • Targeted Biopsy System
  • TargetScan Technology
  • TargetScan Advantages
  • TargetScan Touch Simulator
•    |   
• Professionals
  • Clinical Data
  • TargetScan Specifications
  • TargetScan Literature
•    |   
• Patients
  • Detection
    • Prostate Ultrasound
    • TRUS Ultrasound
    • Benign Prostatic Hyperplasia
    • Prostate Specific Antigen
  • Treatments
    • Brachytherapy
    • Cryotherapy
    • HIFU
    • HDR
  • Patient Experiences
•    |   
• About Prostate Cancer
  • Prostate Cancer Stages
  • Prostate Cancer Biopsy
  • Prostate Cancer Prevention

HDR (High Dose Rate) Brachytherapy

High-Dose Rate (HDR) Brachytherapy is an innovative form of internal radiotherapy. As comprehensive, aggressive approach to prostate cancer treatment, HDR is a more prescise delivery method of brachytherapy delivering a therapeutic dose of radiation through temporarily placed needles, catheters, or other applicators. HDR treatments do not include the use of a permanent implant and may greatly reduce recovery time, as well as reduce the likelihood of impotence and the risk of incontinence when compared to radical prostatectomy.

HDR Brachytherapy is not an outpatient procedure. Due to the temporary catheters implanted in the prostate (24 – 36 hours), a hospital stay is required. The implant procedure typically takes 3-4 hours, which allows for the improved accuracy of treatment. HDR benefits include preservation of organ structure and function, fewer side effects, strong coverage if possible microscopic extension of prostate cancer, and accuracy and precision of delivery.